Maxisulin, created in 1996 (Germany), from 223 sister brands and 17478 competing brands. The Maxisulin brand is owned by Daiichi Sankyo, a company listed in Francfort. Its International Securities Identification Number (ISIN) is JP3475350009. Maxisulin belongs to the Drug Manufacturers business sector.